BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3313898)

  • 1. Expression of class II antigens in human renal allografts: comparison of acute rejection, chronic rejection, and cyclosporine nephrotoxicity.
    Toma H; Tanabe K; Oba S; Horita S; Takahashi K; Teraoka S; Ota K
    Transplant Proc; 1987 Oct; 19(5):3719-20. PubMed ID: 3313898
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection--implications for development of a possible diagnostic marker.
    Osterholm C; Veress B; Simanaitis M; Hedner U; Ekberg H
    Transpl Immunol; 2005 Dec; 15(2):165-72. PubMed ID: 16412961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistological analysis of renal allograft biopsies from cyclosporin-treated patients. Induced HLA-class II antigen expression does not exclude a diagnosis of cyclosporin nephrotoxicity.
    Fuggle SV; McWhinnie DL; Morris PJ
    Transpl Int; 1989 Oct; 2(3):123-8. PubMed ID: 2679626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA class II induction and cellular infiltration are effectively suppressed by triple therapy in renal allografts.
    McWhinnie DL; Fuggle SV; Azevedo LS; Jones RM; Morris PJ
    Transplant Proc; 1987 Oct; 19(5):3628-9. PubMed ID: 3313873
    [No Abstract]   [Full Text] [Related]  

  • 5. HLA-class II antigen induction does not exclude a diagnosis of cyclosporine nephrotoxicity.
    Fuggle SV; McWhinnie DL; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1525-6. PubMed ID: 2652491
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
    Diethelm AG
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo immunosuppressive effect and the decreasing expression of MHC class II antigens by purine nucleoside phosphorylase inhibitor 8-amino-9-benzylguanine in recipient tissues of canine renal allograft rejection.
    Yen CY; Lin CY
    J Surg Res; 1996 May; 62(2):260-6. PubMed ID: 8632649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic renal allograft rejection in the rat. Transplantation-induced antibodies against basement membrane antigens.
    de Heer E; Davidoff A; van der Wal A; van Geest M; Paul LC
    Lab Invest; 1994 Apr; 70(4):494-502. PubMed ID: 8176888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of cyclosporine A-induced nephrotoxicity from acute rejection in renal transplantation using fine-needle aspiration biopsies.
    Zannier A; Mutin M; Touraine JL; Traeger J
    Transplant Proc; 1987 Oct; 19(5):3630-2. PubMed ID: 3313874
    [No Abstract]   [Full Text] [Related]  

  • 10. HLA class II and IL-2R expression in acute vascular rejection of human kidney allografts.
    von Willebrand E; Salmela K; Isoniemi H; Taskinen E; Krogerus L; Häyry P
    Transplant Proc; 1992 Feb; 24(1):303-4. PubMed ID: 1539286
    [No Abstract]   [Full Text] [Related]  

  • 11. Morphological patterns in cyclosporine-treated renal transplant recipients.
    Mihatsch MJ; Thiel G; Basler V; Ryffel B; Landmann J; von Overbeck J; Zollinger HU
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):101-16. PubMed ID: 3895652
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of class II major histocompatibility complex antigen expression for the differential diagnosis of cyclosporine A nephrotoxicity from kidney graft rejection.
    Barrett M; Milton AD; Barrett J; Taube D; Bewick M; Parsons VP; Fabre JW
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1769-71. PubMed ID: 3152634
    [No Abstract]   [Full Text] [Related]  

  • 13. Rejection-related nephrotic syndrome associated with massive antiglomerular and antitubular basement membrane deposits.
    Zevin D; Ben-Bassat M; Weinstein T; Shapira Z; Levi J
    Isr J Med Sci; 1985 Nov; 21(11):915-8. PubMed ID: 3908399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between intercellular adhesion molecule-1 and HLA class II expression in acute cellular rejection of human kidney allografts.
    von Willebrand E; Loginov R; Salmela K; Isoniemi H; Häyry P
    Transplant Proc; 1993 Feb; 25(1 Pt 2):870-1. PubMed ID: 8095111
    [No Abstract]   [Full Text] [Related]  

  • 15. The genesis of glomerulonephritis in renal transplants.
    Merrill JP
    Adv Nephrol Necker Hosp; 1971; 1():65-73. PubMed ID: 5006259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and histologic characteristics of chronic renal allograft rejection.
    Paul LC
    Clin Transplant; 1994 Jun; 8(3 Pt 2):319-23. PubMed ID: 8061373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of electron microscopy in the diagnosis of chronic renal allograft rejection.
    Ivanyi B; Kemeny E; Szederkenyi E; Marofka F; Szenohradszky P
    Mod Pathol; 2001 Dec; 14(12):1200-8. PubMed ID: 11743041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence against chronic progressive cyclosporine nephrotoxicity.
    Ben-Maimon CS; Burke JF; Besarab A; Jarrell BE; Francos GC; Moyer SS
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1260-2. PubMed ID: 1989206
    [No Abstract]   [Full Text] [Related]  

  • 19. Intrarenal distribution of endothelial antigens recognized by antibodies from renal allograft recipients.
    Paul LC; van Es LA; Kalff MW; de Graeff J
    Transplant Proc; 1979 Mar; 11(1):427-30. PubMed ID: 377670
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood eosinophilia and major histocompatibility complex II expression in renal allograft rejection.
    Pecorella I; Ciardi A; Pretagostini R; Caricato M; Forti A; Berloco P; Alfani D; Di Tondo U; Cortesini R
    Transplant Proc; 1988 Aug; 20(4):606-7. PubMed ID: 3043813
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.